Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
| Published in: | JAC-Antimicrobial Resistance |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868553802900045825 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | JAC-Antimicrobial Resistance |
| description | |
| discipline_display | Internal Medicine |
| discipline_facet | Internal Medicine |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:88944 |
| institution | FRELIP |
| journal_source_facet | JAC-Antimicrobial Resistance |
| last_indexed | 2026-06-20T21:42:46.854Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens Internal Medicine General Internal Medicine |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Internal Medicine General Internal Medicine |
| subject_facet | Internal Medicine General Internal Medicine |
| title | Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens |
| title_alt | Actualización sobre la actividad comparativa in vitro de cefiderocol y cuatro combinaciones de β-lactámico–β-lactamasa-inhibidor contra patógenos Gram-negativos clínicamente importantes Mise à jour sur l'activité comparative in vitro du céfidérocol et de quatre combinaisons β-lactamine–inhibiteur de β-lactamase contre des pathogènes Gram-négatifs cliniquement importants Atualização sobre a atividade comparativa in vitro de cefiderocol e quatro combinações de β-lactâmico–β-lactamase-inibidor contra patógenos Gram-negativos clinicamente importantes |
| title_auth | Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens |
| title_es_txt | Actualización sobre la actividad comparativa in vitro de cefiderocol y cuatro combinaciones de β-lactámico–β-lactamasa-inhibidor contra patógenos Gram-negativos clínicamente importantes |
| title_fr_txt | Mise à jour sur l'activité comparative in vitro du céfidérocol et de quatre combinaisons β-lactamine–inhibiteur de β-lactamase contre des pathogènes Gram-négatifs cliniquement importants |
| title_full | Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens |
| title_fullStr | Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens |
| title_full_unstemmed | Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens |
| title_pt_txt | Atualização sobre a atividade comparativa in vitro de cefiderocol e quatro combinações de β-lactâmico–β-lactamase-inibidor contra patógenos Gram-negativos clinicamente importantes |
| title_short | Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens |
| title_sort | update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important gram-negative pathogens |
| topic | Internal Medicine General Internal Medicine |
| url | https://academic.oup.com/jacamr/article/doi/10.1093/jacamr/dlag103/8703636?rss=1 |